LifeMD, Inc. Faces Class Action Lawsuit - What Investors Need to Know
Levi & Korsinsky, LLP is reaching out to investors regarding an important class action lawsuit involving LifeMD, Inc. (NASDAQ: LFMD). This is crucial for shareholders who may have suffered losses during the specific time frame outlined in the lawsuit.
Understanding the Class Action Lawsuit
The lawsuit aims to address grievances faced by investors adversely impacted by alleged securities fraud. It specifically covers a period of time where key concerns were raised about the accuracy of LifeMD's financial disclosures. The allegations include significant misstatements regarding the company's competitive position and the inflation of its revenue forecasts.
Key Allegations Against LifeMD
According to the lawsuit, the defendants, including executives at LifeMD, made false claims that misled investors about the company's business operations. It was stated that LifeMD's guidance for 2025 did not accurately reflect the growing customer acquisition costs associated with critical segments of its business, particularly in the sale of obesity treatment drugs. These statements were deemed materially misleading, affecting investor decisions.
Important Deadlines for Investors
Investors in LifeMD, Inc. have until October 25, 2025, to act regarding this lawsuit. Those who have incurred losses during the specified period should consider seeking the appointment as lead plaintiff in the case. However, it’s noteworthy that participation in any potential recovery does not require being a lead plaintiff.
No Financial Risk to Class Members
Individuals who qualify as class members in this lawsuit have the opportunity to seek compensation without any upfront costs or fees. This means that participation comes with no financial obligation, which can greatly benefit those who were misled.
Why Choose Levi & Korsinsky?
Levi & Korsinsky has earned a distinguished reputation over the past two decades, securing substantial settlements for investors embroiled in complex securities disputes. Their expertise in this field, along with a dedicated team of over 70 professionals, showcases their commitment to representing investor interests effectively. The firm has been recognized consistently, including a notable placement in the ISS Securities Class Action Services' Top 50 Report.
Contact Information for Assistance
For investors who wish to reach out for more details or assistance concerning this lawsuit, please contact:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
Tel: (212) 363-7500
Fax: (212) 363-7171
Frequently Asked Questions
What is the class action lawsuit against LifeMD about?
The lawsuit addresses allegations of securities fraud that negatively impacted LifeMD investors, specifically false statements and misleading guidance.
What is the deadline for investors?
Investors have until October 25, 2025, to request to be appointed as lead plaintiff in the lawsuit.
How can investors participate in the lawsuit?
Investors can join the lawsuit without needing to be the lead plaintiff, and they may be eligible for compensation without facing any costs.
Why should investors trust Levi & Korsinsky?
Levi & Korsinsky has a strong track record of securing favorable outcomes for shareholders and is recognized as a leading firm in securities litigation.
Who can I contact for more information?
Interested investors can contact Levi & Korsinsky at their New York office or by calling (212) 363-7500 for further assistance regarding the lawsuit.
